Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
In Phase 2 trials, dosing began at 2 mg once weekly subcutaneously, with incremental increases at approximately 4-weekly intervals up to 12 mg
The product must be prescribed and administered by qualified practitioners who can screen for contraindications, monitor real-time hemodynamics, and intervene promptly should infusion-related adverse events arise
If the data is incomplete or incorrect, you can complete or correct it by editing this page.
No specific study is named
Melanoma is cancer of what part of the body
US$ 26.78
US$ 23.73
US$ 26.97
US$ 21.42
US$ 21.94
US$ 28.07
US$ 21.32
US$ 20.83
